158 related articles for article (PubMed ID: 23207931)
21. Simplified identification of Lynch syndrome: a prospective, multicenter study.
Bonnet D; Selves J; Toulas C; Danjoux M; Duffas JP; Portier G; Kirzin S; Ghouti L; Carrère N; Suc B; Alric L; Barange K; Buscail L; Chaubard T; Imani K; Guimbaud R
Dig Liver Dis; 2012 Jun; 44(6):515-22. PubMed ID: 22480969
[TBL] [Abstract][Full Text] [Related]
22. Daily aspirin reduces colorectal cancer incidence in patients with Lynch syndrome.
Barton MK
CA Cancer J Clin; 2012; 62(3):143-4. PubMed ID: 22411104
[No Abstract] [Full Text] [Related]
23. The proportion of endometrial tumours associated with Lynch syndrome (PETALS): A prospective cross-sectional study.
Ryan NAJ; McMahon R; Tobi S; Snowsill T; Esquibel S; Wallace AJ; Bunstone S; Bowers N; Mosneag IE; Kitson SJ; O'Flynn H; Ramchander NC; Sivalingam VN; Frayling IM; Bolton J; McVey RJ; Evans DG; Crosbie EJ
PLoS Med; 2020 Sep; 17(9):e1003263. PubMed ID: 32941469
[TBL] [Abstract][Full Text] [Related]
24. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
Carethers JM; Stoffel EM
World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
[TBL] [Abstract][Full Text] [Related]
25. [Recognition of congenital endometrial carcinoma: the importance of family history and investigation of microsatellite instability in the tumour].
Hoogerbrugge N; Overbeek LI; de Hullu J; Kets CM; Hebeda KM; Ligtenberg MJ
Ned Tijdschr Geneeskd; 2007 Jun; 151(26):1441-4. PubMed ID: 17633970
[TBL] [Abstract][Full Text] [Related]
26. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.
Burn J; Bishop DT; Mecklin JP; Macrae F; Möslein G; Olschwang S; Bisgaard ML; Ramesar R; Eccles D; Maher ER; Bertario L; Jarvinen HJ; Lindblom A; Evans DG; Lubinski J; Morrison PJ; Ho JW; Vasen HF; Side L; Thomas HJ; Scott RJ; Dunlop M; Barker G; Elliott F; Jass JR; Fodde R; Lynch HT; Mathers JC;
N Engl J Med; 2008 Dec; 359(24):2567-78. PubMed ID: 19073976
[TBL] [Abstract][Full Text] [Related]
27. Chemoprevention of hereditary colon cancers: time for new strategies.
Ricciardiello L; Ahnen DJ; Lynch PM
Nat Rev Gastroenterol Hepatol; 2016 Jun; 13(6):352-61. PubMed ID: 27095653
[TBL] [Abstract][Full Text] [Related]
28. Women with double primary cancers of the colorectum and endometrium: do they have Lynch syndrome?
Song T; Kim MK; Lee YY; Choi CH; Kim TJ; Lee JW; Bae DS; Kim BG
Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():208-12. PubMed ID: 26298861
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part II. The utility of microsatellite instability testing.
Zhang L
J Mol Diagn; 2008 Jul; 10(4):301-7. PubMed ID: 18556776
[TBL] [Abstract][Full Text] [Related]
30. Lynch Syndrome: From Screening to Diagnosis to Treatment in the Era of Modern Molecular Oncology.
Cohen SA; Pritchard CC; Jarvik GP
Annu Rev Genomics Hum Genet; 2019 Aug; 20():293-307. PubMed ID: 30848956
[TBL] [Abstract][Full Text] [Related]
31. [Tumour examination to detect hereditary colorectal cancer].
Hoogerbrugge N; Hermens RP; Nagengast F; Overbeek L; van Krieken HJ; Ligtenberg M
Ned Tijdschr Geneeskd; 2012; 156(42):A4982. PubMed ID: 23075775
[TBL] [Abstract][Full Text] [Related]
32. Frequent mismatch-repair defects link prostate cancer to Lynch syndrome.
Dominguez-Valentin M; Joost P; Therkildsen C; Jonsson M; Rambech E; Nilbert M
BMC Urol; 2016 Mar; 16():15. PubMed ID: 27013479
[TBL] [Abstract][Full Text] [Related]
33. Challenges in the diagnosis and management of Lynch Syndrome in an Indigenous family living in a remote West Australian community.
Schofield L; Goldblatt J; Iacopetta B
Rural Remote Health; 2011; 11(4):1836. PubMed ID: 22188021
[TBL] [Abstract][Full Text] [Related]
34. DNA mismatch repair deficiency in sporadic colorectal cancer and Lynch syndrome.
Poulogiannis G; Frayling IM; Arends MJ
Histopathology; 2010 Jan; 56(2):167-79. PubMed ID: 20102395
[TBL] [Abstract][Full Text] [Related]
35. DNA mismatch repair deficiency and hereditary syndromes in Latino patients with colorectal cancer.
Ricker CN; Hanna DL; Peng C; Nguyen NT; Stern MC; Schmit SL; Idos GE; Patel R; Tsai S; Ramirez V; Lin S; Shamasunadara V; Barzi A; Lenz HJ; Figueiredo JC
Cancer; 2017 Oct; 123(19):3732-3743. PubMed ID: 28640387
[TBL] [Abstract][Full Text] [Related]
36. Metachronous serrated neoplasia is uncommon after right colectomy in patients with methylator colon cancers with a high degree of microsatellite instability.
Messick CA; Kravochuck S; Church JM; Kalady MF
Dis Colon Rectum; 2014 Jan; 57(1):39-46. PubMed ID: 24316944
[TBL] [Abstract][Full Text] [Related]
37. Point: justification for Lynch syndrome screening among all patients with newly diagnosed colorectal cancer.
Hampel H
J Natl Compr Canc Netw; 2010 May; 8(5):597-601. PubMed ID: 20495086
[TBL] [Abstract][Full Text] [Related]
38. RE: Aspirin, Ibuprofen, and the Risk for Colorectal Cancer in Lynch Syndrome.
Tuccori M; Filion KB; Azoulay L
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26711870
[No Abstract] [Full Text] [Related]
39. Targeted Cancer Next-Generation Sequencing as a Primary Screening Tool for Microsatellite Instability and Lynch Syndrome in Upper Gastrointestinal Tract Cancers.
Christakis AG; Papke DJ; Nowak JA; Yurgelun MB; Agoston AT; Lindeman NI; MacConaill LE; Sholl LM; Dong F
Cancer Epidemiol Biomarkers Prev; 2019 Jul; 28(7):1246-1251. PubMed ID: 31028081
[TBL] [Abstract][Full Text] [Related]
40. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
